Syria vs Tajikistan: HIV-positive TB patients on ART (antiretroviral therapy)
Syria
100.0%
in 2021
Tajikistan
100.0%
in 2024
Syria rank
1st
Tajikistan rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Syria
- Tajikistan
How they compare
Syria currently reports 100.0% against 100.0% in Tajikistan, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2007 it was Syria ahead.
Syria ranks 1st and Tajikistan ranks 1st of 144 countries.
Syria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Syria | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 28.0% | 72.0% | Syria |
| 2010s | 100.0% | 76.3% | 23.7% | Syria |
| 2020s | 100.0% | 99.0% | 1.0% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Syria or Tajikistan?
- Syria, at 100.0% against 100.0% in Tajikistan as of 2021.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Syria and Tajikistan?
- 0.0%, with Syria ahead.
- How many years of comparable data are there for Syria and Tajikistan?
- 10 years are reported by both, from 2007 to 2021.
- How do Syria and Tajikistan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Syria ranks 1st and Tajikistan ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.